Analytisch-biologisches Forschungslabor

ABF (Analytisch-biologisches Forschungslabor) is a specialized contract research organization (CRO) based in Munich, Germany, that provides high-end bioanalytical services. Founded in 1989, the laboratory focuses on the development and validation of biomarkers using advanced mass spectrometry techniques, including LC-MS/MS and GC-MS/MS. The company serves a diverse range of sectors, including the pharmaceutical industry, environmental medicine, and the tobacco and nicotine industry. ABF offers comprehensive support for clinical trials (Phase I-IV) and is fully compliant with GLP and GCP standards. In 2021, the company was acquired by the GBA Group, integrating its expertise into a broader international laboratory network.